Product Information

SELEGILINE HCL 5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.9041 per EA under NDC 60505343803. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Jun 6, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SELEGILINE HCL 5 MG TABLET

Selegiline Hydrochloride
$0.9041per EA

Strength

5 mg/1

Manufacturer

Apotex Corp.

NDC

60505343803

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SELEGILINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074871

FDA Approved

6/6/1997

TE Code

AB

On Market Since

7/6/1997

Pharmacological Classes

Monoamine Oxidase Inhibitor
Monoamine Oxidase Inhibitors
Monoamine Oxidase Type B Inhibitor
Monoamine Oxidase-B Inhibitors

Price Statistics

The NADAC for SELEGILINE HCL 5 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 46.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9041 per EA
All-time high$2.1399 (Jul 16, 2014)
All-time low$0.6101 (Jul 17, 2024)
52-week high$0.9041
52-week low$0.6895
Median price$1.0888
Average price$1.1329
Largest weekly change+42.1% (Oct 18, 2017)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+12.0%

1M

+18.1%

3M

+14.1%

6M

+19.2%

1Y

+17.4%

3Y

+6.7%

5Y

-21.6%

All

-46.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SELEGILINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SELEGILINE HCL 5 MG TABLET, manufactured by Apotex Corp., is $0.9041 per EA (NDC 60505343803), effective Nov 18, 2026.

How has the price of SELEGILINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SELEGILINE HCL 5 MG TABLET has declined 46.4%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SELEGILINE HCL 5 MG TABLET?

Since Nov 28, 2013, the NADAC for SELEGILINE HCL 5 MG TABLET has ranged from a low of $0.6101 (Jul 17, 2024) to a high of $2.1399 (Jul 16, 2014), with a median of $1.0888 per EA.

Are there cheaper alternatives to SELEGILINE HCL 5 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SELEGILINE HCL 5 MG TABLET, is $0.6101 per EA — about 33% below SELEGILINE HCL 5 MG TABLET.

Who manufactures SELEGILINE HCL 5 MG TABLET?

SELEGILINE HCL 5 MG TABLET (NDC 60505343803) is labeled by Apotex Corp., and CMS classifies it as a generic product.